Email Alert RSS
Volume 12 Issue 6
Nov.  2021
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2021  >  12(6): 965-971
ZHAO Zhe, WANG Tao, TANG Yan, CHEN Xiaoguang, ZHAO Bin. Acute Generalized Exanthematous Pustulosis Caused by Proton Pump Inhibitors: A Real-World Pharmacovigilance Study[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 965-971. doi: 10.12290/xhyxzz.20200262
Citation: ZHAO Zhe, WANG Tao, TANG Yan, CHEN Xiaoguang, ZHAO Bin. Acute Generalized Exanthematous Pustulosis Caused by Proton Pump Inhibitors: A Real-World Pharmacovigilance Study[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 965-971. doi: 10.12290/xhyxzz.20200262
shu

Acute Generalized Exanthematous Pustulosis Caused by Proton Pump Inhibitors: A Real-World Pharmacovigilance Study

doi: 10.12290/xhyxzz.20200262
  • 1.

    Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China

  • 3.

    Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

More Information
  • Corresponding author: ZHAO Bin  Tel: 86-10-69156513, E-mail: zhaobin@pumch.cn
  • Received Date: 2020-10-15
  • Accepted Date: 2020-11-30
    • Available Online: 2021-06-28
  • Publish Date: 2021-11-30
    Abstract
  •   Objective  To explore and compare the associations of different proton pump inhibitors (PPIs) with acute generalized exanthematous pustulosis (AGEP).  Methods  Data were obtained from the database of Food and Drug Administration's adverse event reporting system (FAERS) from January 2004 to June 2020. Non-proportional analysis and Bayesian analysis were utilized to analyze the signs of AGEP caused by different PPIs. The onset time and prognosis of PPIs-related AGEP were also analyzed.  Results  A total of 162 cases of AGEP caused by PPIs were reported. The most frequently used PPI was omeprazole (33.95%, 55/162), followed by esomeprazole (29.63%, 48/162) and pantoprazole (26.54%, 43/162). Pantoprazole showed the strongest correlation with AGEP, followed by omeprazole and lansoprazole, while esomeprazole appeared to have a weaker association with AGEP than other PPIs. The median time to the onset of AGEP was 6 (2, 12) days after PPI treatment, and 60.00%-83.33% of patients developed symptoms within 10 days after the medication (except rabeprazole). PPI-associated AGEP generally led to a fatality of 1.86% (3 cases) and a hospitalization rate of 79.50% (128 cases). The hospitalization rate of AGEP patients caused by omeprazole was the highest (91.49%, 43/47), followed by that of pantoprazole (88.37%, 38/43), lansoprazole (85.71%, 12/44), and omeprazole (61.82%, 34/55).  Conclusions  Our pharmacovigilance study based on the FAERS database demonstrated in detail the risks and characteristics of AGEP caused by different PPIs, which could provide a theoretical basis for rational clinical drug use.
    • FullText(HTML)
  • loading
    • References(27)
  • [1] Shin JM, Cho YM, Sachs G. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors[J]. J Am Chem Soc, 2004, 126: 7800-7811. doi:  10.1021/ja049607w
    [2] Yu LY, Sun LN, Zhang XH, et al. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors[J]. Adv Ther, 2017, 34: 1070-1086. doi:  10.1007/s12325-017-0532-9
    [3] Sidoroff A. Acute generalized exanthematous pustulosis[J]. Chem Immunol Allergy, 2012, 97: 139-148. doi:  10.1159/000335625
    [4] Dewerdt S, Vaillant L, Machet L, et al. Acute generalized exanthematous pustulosis induced by lansoprazole[J]. Acta Derm Venereol, 1997, 77: 250. http://europepmc.org/abstract/MED/9188895
    [5] Nantes Castillejo O, Zozaya Urmeneta JM, Valcayo Peñalba A, et al. Acute generalized exanthematous pustulosis induced by omeprazole[J]. Gastroenterol Hepatol, 2008, 31: 295-298. doi:  10.1157/13119883
    [6] Schmitz B, Sorrells T, Glass JS. Acute generalized exanthematous pustulosis caused by pantoprazole[J]. Cutis, 2018, 101: E22-E23. http://www.onacademic.com/detail/journal_1000040410316010_32f7.html
    [7] 中国临床医学真实世界研究施行规范专家委员会. 中国临床医学真实世界研究施行规范[J]. 中华实验和临床感染病杂志(电子版), 2017, 11: 521-525.

    Academic Committee of Chinese Practice Algorithm on Real World Study of Clinical Medicine. Chinese practice algorithm on real world study of clinical medicine[J]. Zhonghua Shiyan He Linchuang Ganranbing Zazhi (Dianziban), 2017, 11: 521-525.
    [8] Gargoloff PD, Corral R, Herbst L, et al. Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study[J]. Hum Psychopharmacol, 2016, 31: 412-418. doi:  10.1002/hup.2557
    [9] Quackenbush D, Allen JG, Fowler JC. Comparison of Attachments in Real-World and Virtual-World Relationships[J]. Psychiatry, 2015, 78: 317-327. doi:  10.1080/00332747.2015.1092854
    [10] Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports[J]. Pharmacoepidemiol Drug Saf, 2001, 10: 483-486. doi:  10.1002/pds.677
    [11] Sakaeda T, Tamon A, Kadoyama K, et al. Data mining of the public version of the FDA Adverse Event Reporting System[J]. Int J Med Sci, 2013, 10: 796-803. doi:  10.7150/ijms.6048
    [12] Van Puijenbroek EP, Bate A, Leufkens HG, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions[J]. Pharmacoepidemiol Drug Saf, 2002, 11: 3-10. doi:  10.1002/pds.668
    [13] Natsch S, Vinks MH, Voogt AK, et al. Anaphylactic reactions to proton-pump inhibitors[J]. Ann Pharmacother, 2000, 34: 474-476. doi:  10.1345/aph.19235
    [14] Bose S, Guyer A, Long A, et al. Evaluation and manage-ment of hypersensitivity to proton pump inhibitors[J]. Ann Allergy Asthma Immunol, 2013, 111: 452-457. doi:  10.1016/j.anai.2013.08.022
    [15] Lin CY, Wang CW, Hui CR, et al. Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity study[J]. Allergy, 2018, 73: 221-229. doi:  10.1111/all.13235
    [16] Britschgi M, Steiner UC, Schmid S, et al. T-cell involve-ment in drug-induced acute generalized exanthematous pustulosis[J]. J Clin Invest, 2001, 107: 1433-1441. doi:  10.1172/JCI12118
    [17] Sidoroff A, Dunant A, Viboud C, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR)[J]. Br J Dermatol, 2007, 157: 989-996. doi:  10.1111/j.1365-2133.2007.08156.x
    [18] Schaerli P, Britschgi M, Keller M, et al. Characterization of human T cells that regulate neutrophilic skin inflammation[J]. J Immunol, 2004, 173: 2151-2158. doi:  10.4049/jimmunol.173.3.2151
    [19] Kakeda M, Schlapbach C, Danelon G, et al. Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis[J]. Arch Dermatol Res, 2014, 306: 933-938. doi:  10.1007/s00403-014-1488-0
    [20] Kabashima R, Sugita K, Sawada Y, et al. Increased circulating Th17 frequencies and serum IL-22 levels in patients with acute generalized exanthematous pustulosis[J]. J Eur Acad Dermatol Venereol, 2011, 25: 485-488. doi:  10.1111/j.1468-3083.2010.03771.x
    [21] Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern[J]. J Cutan Pathol, 2001, 28: 113-119. doi:  10.1034/j.1600-0560.2001.028003113.x
    [22] Ahrens D, Chenot JF, Behrens G, et al. Appropriateness of treatment recommendations for PPI in hospital discharge letters[J]. Eur J Clin Pharmacol, 2010, 66: 1265-1271. doi:  10.1007/s00228-010-0871-9
    [23] Ying J, Li LC, Wu CY, et al. The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China[J]. Rev Esp Enferm Dig, 2019, 111: 738-743. http://www.ncbi.nlm.nih.gov/pubmed/31373505
    [24] Thienvibul C, Vachiramon V, Chanprapaph K. Five-Year Retrospective Review of Acute Generalized Exanthematous Pustulosis[J]. Dermatol Res Pract, 2015, 2015: 260928. http://www.onacademic.com/detail/journal_1000040466855610_13cb.html
    [25] Li XQ, Andersson TB, Ahlström M, et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities[J]. Drug Metab Dispos, 2004, 32: 821-827. doi:  10.1124/dmd.32.8.821
    [26] Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases[J]. Arch Dermatol, 1991, 127: 1333-1338. doi:  10.1001/archderm.1991.01680080069004
    [27] Patek TM, Teng C, Kennedy KE, et al. Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)[J]. Drug Saf, 2020, 43: 17-22. doi:  10.1007/s40264-019-00873-8
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (580) PDF downloads(57) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return